Mette-Marit lung transplant plans are now central to Norway’s royal calendar after the Royal Palace announced that Crown Princess Mette-Marit has been placed on the waiting list for a lung transplant following a serious deterioration in her chronic lung disease.
The Crown Princess, 52, was diagnosed in 2018 with pulmonary fibrosis, a chronic condition that causes scarring in the lungs and reduces the body’s ability to absorb oxygen. According to the Norwegian Royal House (Det kongelige hoff), she has undergone extensive medical examinations and will receive a transplant as soon as this is medically possible.
A serious deterioration in Mette-Marit’s lung disease
The announcement marks a significant escalation in the Crown Princess’s health situation. Are Holm, senior consultant and lung specialist at Rikshospitalet in Oslo, said the development of her disease is “serious” and that doctors had now concluded she should be placed on the transplant list.
At a press briefing on Friday, Holm said Mette-Marit’s condition had worsened considerably over the past six months, with a particularly sharp decline during the last three months. Without a transplant, doctors told reporters, her expected life expectancy would likely be around one year.
Pulmonary fibrosis is a progressive disease. In severe cases, a lung transplant may become the only treatment able to extend life and improve quality of life. The decision to place a patient on a transplant list is therefore both urgent and selective: the patient must be ill enough to need new lungs, but also strong enough to withstand a complex operation and the long treatment that follows.
How Norway’s lung transplant system works
The Royal Palace and Norwegian medical authorities have stressed that Mette-Marit’s royal status does not give her priority over other patients. Doctors decide who receives a transplant based on medical criteria, including severity of illness, suitability for surgery, blood type, organ size and tissue compatibility.
Lung transplantation is among the most demanding forms of organ transplant. Specialists cited by Norwegian media describe it as a high-risk operation, often lasting between six and twelve hours. The patient may need support from a heart-lung machine, and the post-operative period carries risks including infection, bleeding and rejection of the new organs.
Norway performs a limited number of lung transplants each year. In 2025, 36 such operations were carried out at Rikshospitalet, the national centre for this type of surgery. Survival rates in Norway are considered relatively strong by international standards, but patients require lifelong treatment with immunosuppressive medication to reduce the risk of rejection.
Royal duties are being reduced around the transplant
Until the operation has taken place, Mette-Marit will not be able to work or carry out official duties as normal. The palace said her condition will also affect the programme of Crown Prince Haakon and the wider Crown Prince Family (Kronprinsfamilien).
Haakon, the heir to the Norwegian throne, will adjust his schedule to spend more time with his wife before and after the operation. He will limit longer trips in Norway and abroad, and will not attend the Swedish royal couple’s golden wedding anniversary celebration in Stockholm on 13 June as previously planned.
The couple have also postponed the celebration of their silver wedding anniversary, which had been scheduled for August 2026. Mette-Marit will not take part in a planned county visit in September.
The changes underline the institutional importance of the Crown Prince Couple in Norway’s constitutional monarchy. Haakon remains central to the royal family’s public duties, but the palace is now preparing for a period in which health and family considerations will reshape the official calendar.
Ingrid Alexandra returns to Oslo as the family regroups
The Crown Princess’s health situation is also affecting the plans of her children. Princess Ingrid Alexandra has returned to Norway and will spend the autumn semester of 2026 at the University of Oslo instead of continuing her exchange at the University of Sydney.
Prince Sverre Magnus is expected to study in Europe from the autumn, but the palace said he will return to Norway when the situation requires it.
The family adjustments come at a difficult time for the Norwegian royal household. In recent months, the monarchy has faced public pressure linked to the criminal case involving Marius Borg Høiby, Mette-Marit’s eldest son, as well as renewed scrutiny of the Crown Princess’s past contacts with Jeffrey Epstein. The health crisis now adds a more personal and medically urgent dimension to an already sensitive period.
A personal health crisis with public consequences
Mette-Marit has been unusually open about her illness since her diagnosis became public in 2018. That openness has shaped the way Norway has followed the progression of her condition, from reduced public duties to the latest announcement that she is now waiting for new lungs.
For the Norwegian monarchy, the coming months will be marked by uncertainty. A suitable donor organ must become available, the operation must be carried out successfully, and the recovery process will likely require a long period away from public life.
The palace has not given a timetable, because transplantation depends on medical compatibility and donor availability. What is clear is that the Mette-Marit lung transplant is now both a private family emergency and a public matter for Norway’s royal institution, with consequences for official duties, royal visibility and the future rhythm of the Crown Prince Family.
